123 related articles for article (PubMed ID: 2114988)
1. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis.
Schöni MH; Türler K; Käser H; Kraemer R
Eur J Clin Invest; 1990 Jun; 20(3):272-8. PubMed ID: 2114988
[TBL] [Abstract][Full Text] [Related]
2. [Determination of free and conjugated catecholamines, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid in the urine and blood plasma by high pressure liquid chromatography].
Kogan BM; Drozdov AZ; Man'kovskaia IV; Filatova TS
Klin Lab Diagn; 1995; (3):25-8. PubMed ID: 8689050
[TBL] [Abstract][Full Text] [Related]
3. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
[TBL] [Abstract][Full Text] [Related]
4. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
Brown MJ; Dollery CT
Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-beta-hydroxylase in patients with cystic fibrosis.
Schöni MH; Türler K; Käser H; Kraemer R
Eur J Pediatr; 1986 Apr; 145(1-2):80-3. PubMed ID: 3732334
[TBL] [Abstract][Full Text] [Related]
6. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
[TBL] [Abstract][Full Text] [Related]
7. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine].
Valori C; Brunori CA; Renzini V; Porcellati C
Ann Ist Super Sanita; 1971; 7(2):414-21. PubMed ID: 5155304
[No Abstract] [Full Text] [Related]
8. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
Benedict CR
J Chromatogr; 1987 Jan; 385():369-75. PubMed ID: 3104375
[TBL] [Abstract][Full Text] [Related]
9. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
10. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
Ben-Jonathan N; Arbogast LA; Rhoades TA; Schillo KK; Pau KY; Jackson GL
Endocrinology; 1983 Jul; 113(1):216-21. PubMed ID: 6407822
[TBL] [Abstract][Full Text] [Related]
11. Plasma and urinary catecholamines in patients with cystic fibrosis.
Schöni MH; Türler K; Käser H; Kraemer R
Pediatr Res; 1985 Jan; 19(1):47-52. PubMed ID: 3969312
[TBL] [Abstract][Full Text] [Related]
12. Dihydroxyphenylalanine secretion in a malignant pheochromocytoma.
Anton AH; Greer M; Sayre DF; Williams CM
Am J Med; 1967 Mar; 42(3):469-75. PubMed ID: 6018863
[No Abstract] [Full Text] [Related]
13. Secretion of dopa in phaeochromocytoma.
Louis WJ; Doyle AE; Heath WC; Robinson MJ
Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512
[TBL] [Abstract][Full Text] [Related]
14. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
Kuchel O
Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
[TBL] [Abstract][Full Text] [Related]
15. [On the determination of adrenaline, noradrenaline, dopamine and dopa in a single urine sample].
Matlina ESh; Kiseleva ZM
Probl Endokrinol Gormonoter; 1966; 12(2):111-6. PubMed ID: 6004103
[No Abstract] [Full Text] [Related]
16. Derivation of urinary dopamine from plasma dopa.
Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
[TBL] [Abstract][Full Text] [Related]
17. [Various features of dopamine metabolism in schizophrenia].
Anokhina IP; Kogan BM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
19. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients.
Karlov VA; Gleiser MA
Neurosci Behav Physiol; 1986; 16(1):49-53. PubMed ID: 3090474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
